Farmaco SRL
Farmaco reported total assets of 17,325 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Feb 2026).
The score of Farmaco shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -83 % Total assets -23 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmaco's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Feb 2026
- Year ended 31 Dec 2024filed on 13 Aug 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 19 Aug 2022
Farmaco's financial analysis
- Solvency5.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmaco
Farmaco's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0746.369.666
- VAT number
- BE0746369666
- Peppol
- Registered · 0208:0746369666 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Apr 2020
- Registered office
- 2520 Ranst
- Latest accounts
- 2025 · filed on 10 Feb 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farmaco (SRL) has been based in Ranst since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 14,717 € and equity of 1,000 €; its revenue is not published. Its solvency stands at 5.8%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farmaco
Companies in the same business, of comparable size and area, outside its group.
- Au Pave D' Ollignies Retail sale of pharmaceutical products Mouscron · balance sheet 7,469 €
- TVB Consult Retail sale of pharmaceutical products Kruisem · balance sheet 17,370 €
- Camille Huby Retail sale of pharmaceutical products Etterbeek · balance sheet 18,562 €
- PharmaSave Retail sale of pharmaceutical products Antwerp · balance sheet 20,063 €
- Kasibel Retail sale of pharmaceutical products Uccle · balance sheet 20,641 €
- Eklosium Retail sale of pharmaceutical products Schaerbeek · balance sheet 21,432 €
- LC Pharma Concept Retail sale of pharmaceutical products Chapelle-lez-Herlaimont · balance sheet 13,961 €
- Apotheek Vandyck Retail sale of pharmaceutical products Anderlecht · balance sheet 21,647 €
Frequently asked questions about Farmaco
What is the revenue of Farmaco?
Farmaco files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmaco?
In Belgium, the VAT number is the company number prefixed with BE: BE0746369666 for Farmaco, if the company is VAT-registered. Its company number (CBE) is 0746.369.666.
Where is the registered office of Farmaco?
According to the CBE register, the registered office of Farmaco is in 2520 Ranst.
What is the equity of Farmaco?
At the close of the 2025 financial year, the equity of Farmaco amounts to 1,000 €, a solvency of 5.8% of total assets.
Who manages Farmaco?
The register lists 1 active mandates at Farmaco. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmaco
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →